HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

906.378

+4.1830.46%

Number of Gainers:2

Number of Losers:6

Number of Flat:5

PE:- -

High:921.662

Open:902.444

Low:902.444

Close:902.195

Volume:8.04M

Turnover:111.73M

Market Cap:149.11B

Float Cap:111.56B

Loading ...

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS

Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%

MT Newswires Live

Press Release: Fosun Pharma Announces 2026 Interim Results

Haohai Biotec Allocates HK$3.94 Million to Buy Back Nearly 250,000 Shares

Sinopharm Group Stock Falls 1.9% in Hong Kong

CICC Keeps Outperform Rating on 3SBIO, Trims Target Price to HK$30.00

Shanghai Haohai Biological Technology (SEHK:6826) Stock Hit By Margin Compression And Profit Drop

Simply Wall St.

HAOHAI BIOTEC Sets October Dividend Date for Interim Payout

China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution

3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline

Simply Wall St.

3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion

Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains

Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Sisram Medical (SEHK:1696) Stock Revenue Growth Masks Sharp Margin Compression

Simply Wall St.

China's 3SBio H1 Net Profit Falls on Higher Expenses

3SBio H1 Revenue RMB 4,526 Million

THOMSON REUTERS

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK1593/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":906.3781,"timestamp":1788227583346,"preClose":902.19464,"halted":0,"volume":8036739,"delay":0,"changeRate":0.004637,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":4.183472,"latestTime":"09-01 09:53:04","open":902.44415,"high":921.6623,"low":902.44415,"amount":111728712,"amplitude":0.021302,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":1.15543,"peRate":10.676298,"turnoverRate":0.000403,"increases":2,"decrements":6,"flats":5,"marketCap":149113725192,"floatMarketCap":111556803528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":921.6623,"amplitude":0.021302,"preClose":902.19464,"low":902.44415,"pbRate":"1.15543","latestPrice":906.3781,"volume":8037239,"delay":0,"open":902.44415,"prevYearClose":1094.978,"prevWeekClose":922.842,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":951.843,"twentyDayClose":946.866,"sixtyDayClose":852.055,"secType":"PLATE","market":"HK","turnoverRate":0.000403,"peRate":10.676298,"marketCap":149113725192,"floatMarketCap":111556803528,"timestamp":1788227586161,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":6,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662641837","title":"Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662641837","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662641837?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:01","pubTimestamp":1787716878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N002:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","00460","BK1593","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662764909","title":"Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662764909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662764909?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:00","pubTimestamp":1787716853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1593","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662581763","title":"Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662581763","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662581763?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:06","pubTimestamp":1787702809,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  reported an attributable net profit of 1.72 billion yuan for the first half, up 1.15% from 1.70 billion yuan a year earlier.Earnings per share stood at 0.65 yuan, inching up from 0.64 yuan in the year-ago period, according to a Tuesday filing with the Hong Kong bourse.Revenue increased 4.75% year over year to 20.4 billion yuan from 19.4 billion yuan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0060","BK0175","BK0012","BK0028","BK0239","BK0196","BK1593","BK1191","BK1515","BK0183","600196","02196","BK0188","BK0187","BK0096","FCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662322847","title":"Press Release: Fosun Pharma Announces 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662322847","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662322847?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:44","pubTimestamp":1787661840,"startTime":"0","endTime":"0","summary":"Globalization Accelerates Value Realization of Innovative DrugsSHANGHAI, Aug. 25, 2026 /PRNewswire/ -- On August 25, Fosun Pharma (\"the Company\", stock code: 600196.SH; 02196.HK) announced its interim","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0060","BK1191","BK0239","BK0188","BK4232","NVIB","02196","BK0096","BK1593","BK0183","BK0175","600196","BK4022","BK1515","R","BK0187","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115247546","title":"Haohai Biotec Allocates HK$3.94 Million to Buy Back Nearly 250,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1115247546","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115247546?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:28","pubTimestamp":1787563693,"startTime":"0","endTime":"0","summary":"Haohai Biotec (06826) announced that on August 24, it spent approximately HK$3.939 million to repurchase 249,600 of its own shares.This buyback reflects the company's ongoing capital management...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221432","title":"Sinopharm Group Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221432?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.9% to 16.33 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.Sinopharm Group Co. Ltd. closed 27% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 3.3%.Trading volume totaled 5.3 million shares, compared to the 50-day average of 5.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0188","BK1500","BK0175","BK0196","BK1593","BK0012","BK0183","01099","600196","BK4175","02196","BK1515","BK1191","BK0096","SHTDY","BK0187","LU0640798160.USD","BK1197","LU1115378108.SGD","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167323330","title":"CICC Keeps Outperform Rating on 3SBIO, Trims Target Price to HK$30.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1167323330","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167323330?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:44","pubTimestamp":1787543093,"startTime":"0","endTime":"0","summary":"CICC has released a research report noting that, considering internal business pressures, it has cut its 2026/2027 net profit forecasts for 3SBIO by 6% and 12% to RMB 2.842 billion and RMB 3.051...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1161","BK1583","BK1593","EWH","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212564","title":"Shanghai Haohai Biological Technology (SEHK:6826) Stock Hit By Margin Compression And Profit Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212564","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212564?lang=en_us&edition=fundamental","pubTime":"2026-08-23 04:27","pubTimestamp":1787430458,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology heads into this earnings season with a stock that has slipped about 18% over the past three months, yet trades on a P/E of 20.7 that still sits below the broader Hong Kong biotech industry. The market has been fixated on dividend yield and headline earnings volatility.\nThe key issue in this Q2 release is the profit squeeze behind those headlines. Trailing net margin is 6.5% compared with 15.4% a year earlier, and the period includes a large one-off loss...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-stock-hit-by","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-stock-hit-by","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180238161","title":"HAOHAI BIOTEC Sets October Dividend Date for Interim Payout","url":"https://stock-news.laohu8.com/highlight/detail?id=1180238161","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180238161?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:32","pubTimestamp":1787319132,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) has announced that it will distribute an interim dividend of RMB 0.25 per share on October 16, 2026.The company confirmed the payment schedule in an official statement, marking...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VIG","BK1593","BK4585","BK4588","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661932892","title":"China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2661932892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661932892?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:25","pubTimestamp":1787318735,"startTime":"0","endTime":"0","summary":"China's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distributionOverviewChina biomedical products maker's half-year revenue fell 9.8% yr/yr to RMB1.17 blnNet profit attrib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU1226287875.USD","BK1191","BK0251","LU1226288170.HKD","01093","LU1226287529.USD","LU1226287792.SGD","LU1152091168.USD","LU0140636845.USD","HK0000165453.HKD","IE0008369823.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1328277881.USD","IE0008368742.USD","LU1993786604.SGD","LU1960683339.HKD","BK1593","LU0501845795.SGD","LU0880133367.SGD","LU1807302812.USD","LU0072913022.USD","LU1951186391.HKD","LU0314109678.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU0326950275.SGD","KURE","BK1161","688366","LU2039709279.SGD","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","LU0315179316.USD","BK0239","IE00B031HY20.USD","LU1008478684.HKD","LU0067412154.USD","BK1521","LU1226288253.USD","06826","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295126","title":"3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295126?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:20","pubTimestamp":1787318409,"startTime":"0","endTime":"0","summary":"3SBio stock closed at HK$17.83 on Friday, roughly flat over the past month, even as the latest half year numbers landed with a heavy focus on profitability. The headline is simple. H1 2026 brought in C¥4,525.985m of revenue, yet the story that matters is margin strength and what that might mean for future earnings power.\nInvestors now face a time horizon test. Trailing earnings growth and a P/E around 4.6x paint one picture. Forecasts that point to declining revenue and earnings over the next...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","01530","VGFPF","DECU","BK1593","FEBU","GXDW","RGLO","BK1583","PMDE","BK1161","JOYT","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250205","title":"3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250205?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:25","pubTimestamp":1787297118,"startTime":"0","endTime":"0","summary":"3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billion3SBio posted first-half 2026 revenue of RMB 4.53 billion, up 3.9% year over year.Net profit attribut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb6tQZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1161","01530","BK1583","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1583","NVIB","IDNA","MEDX","BK1593","01530","GDOC","BMED","BK4232","BK1161","HYLG","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100118644","title":"Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118644","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100118644?lang=en_us&edition=fundamental","pubTime":"2026-08-21 12:09","pubTimestamp":1787285378,"startTime":"0","endTime":"0","summary":"Hong Kong equities advanced in Thursday's morning session, with the benchmark Hang Seng Index adding 184 points to trade 0.72% higher, while the Hang Seng Tech Index gained 0.50%. Total turnover in...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82800","BK1509","LU1152091168.USD","BK1592","BK1594","SG9999001093.SGD","06656","BK1583","01378","BK1559","02833","01530","HK0000252160.HKD","HHImain","LU1770034418.SGD","LU0880133367.SGD","HTImain","00012","06869","03033","09696","BK1543","BK1129","LU2279858448.HKD","LU0264606111.USD","LU0345781412.USD","LU0469268626.HKD","LU0737861699.HKD","BK1593","LU0588546209.SGD","LU0345780950.USD","LU0307460666.USD","03417","LU0067412154.USD","300750","BK1506","LU0287142896.SGD","06896","BK1149","01866","07500","002460","LU0210526637.USD","513600","02837","SG9999006597.SGD","LU0359202008.SGD","BK1170","02800","03115","LU0456827905.SGD","LU1807302812.USD","BK1113","02706","00189","LU1719994722.HKD","HSI","HSTECH","LU1993786604.SGD","HSImain","SG9999014674.SGD","002466","LU0572940350.SGD","83115","09067","601869","09115","HK0001040143.USD","HK0000914660.USD","BK1568","HK0001040168.HKD","BK1523","LU0173614495.USD","BK1175","LU1303224171.USD","BK1586","BK1610","LU1808992512.USD","03419","00354","LU0702159699.USD","LU1251922891.USD","BK1518","03037","601600","LU0359201612.USD","LU1008478684.HKD","BK1526","BK1155","LU0630314457.HKD","BK1116","09088","HK0000252152.HKD","HLDCY","BK1117","LU0051755006.USD","LU0359201885.HKD","03032","07552","03750","07300","LU1166156734.SGD","HK0000165453.HKD","LU1224709979.USD","07200","HK0000286598.CNH","BK1601","LU1171460220.USD","BK1511","MCHmain","03423","01772","BK1589","BK1161","07226","SG9999003461.SGD","BK1207","LU1960683339.HKD","BK1522","BK1500","02600","LU1152091754.HKD","02788","03088","LU0572939691.SGD","LU1023057109.AUD","BK1190","BK1240","BK1513","03067","HK0000914686.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185563343","title":"Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1185563343","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185563343?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:30","pubTimestamp":1787279417,"startTime":"0","endTime":"0","summary":"3SBIO (01530) shares climbed more than 7% in early trading, with the stock last up 6.85% at HK$17.63, on turnover of HK$395 million. The surge follows the company's release of its 2026 interim...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1593","BK4585","VXUS","BK1583","BK4588","KCAI","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258777","title":"Press Release: Sunshine Guojian Releases 2026 Interim Report:","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258777?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:00","pubTimestamp":1787270400,"startTime":"0","endTime":"0","summary":"Innovation-driven, Steady AdvancementSHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as \"Sunshine Guojian\", stock code: 688","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK1161","BK1593","IDNA","BK1583","BK0239","BK4022","GDOC","HYLG","NVIB","MEDX","BK4232","HK0000165453.HKD","688336","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230539","title":"Sisram Medical (SEHK:1696) Stock Revenue Growth Masks Sharp Margin Compression","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230539","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230539?lang=en_us&edition=fundamental","pubTime":"2026-08-21 03:32","pubTimestamp":1787254347,"startTime":"0","endTime":"0","summary":"Sisram Medical stock has been under pressure, down about 27% over the past three months, yet today’s H1 2026 earnings story is not just about the share price slide. The headline is a clear profit squeeze. Revenue edged up to US$171.4m, but adjusted net profit was only US$5.04m, and the net result swung to a small loss. For a medical aesthetics equipment and injectables business that trades on a P/E of 11.1x and pays a 4.46% dividend, the real question now is how much short term margin pain...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/sisram-medical-sehk1696-stock-revenue-growth-masks-sharp-mar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/sisram-medical-sehk1696-stock-revenue-growth-masks-sharp-mar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","BK1585","01696","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","BK1161","BK4567","01177","LU2463526074.USD","IE00BZ08YS42.EUR","BK4533","LU0203345920.USD","BK1583","LU0289739343.SGD","LU0472753341.HKD","HK0000165453.HKD","IE000M9KFDE8.USD","IE00BZ08YR35.GBP","LU0069063385.USD","CMI","LU0124676726.USD","BK1191","BK1589","BK1593","LU0689626769.HKD","LU0511384066.AUD","01530","MADE","LU0289961442.SGD","IE00BZ08YT58.USD","LU0154245756.USD","BK1515","BK4149","BK4585","LU0154245673.USD","BK4588","BK1521","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660591238","title":"3SBio H1 Revenue RMB 4,526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660591238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660591238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:28","pubTimestamp":1787236090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX9N116F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","HK0000165453.HKD","01530","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287767","title":"Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287767","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287767?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233202,"startTime":"0","endTime":"0","summary":"Chinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansionOverviewChina medical device maker's H1 revenue rose 31.1% yr/yr, driven by device sales growthNet profit for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","HK0000165453.HKD","BK1191","SG9999015945.SGD","00656","SG9999015986.USD","BK1230","IE00BVYPNQ40.USD","01696","BK1589","BK1593","IE00BZ08YR35.GBP","BK1583","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","BK1587","BK1521","BK1585","SG9999015978.USD","BK1515","IE00BZ08YT58.USD","01177","00867","IE00BVYPNP33.GBP","BK1100","IE00BYV24P56.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","BK1574","SG9999015952.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":84,"code":"91000000","status":"200"}]}}